“CSL delivered a solid result for the first half of the 2025 financial year led by CSL Behring. Strong demand for many of our market-leading therapies has translated into sales growth, particularly in ...

Glenmark Pharmaceuticals has announced the launch of Clindamycin Phosphate Foam, which is a bioequivalent and therapeutically equivalent to the reference listed drug, Evoclin Foam of Mylan ...

In a report released today, Shane Storey from Wilsons maintained a Hold rating on CSL (CMXHF – Research Report), with a price target of ...

Drugmaker, Mankind Pharma, has announced the sale of its entire stake in Mahananda Spa and Resorts Private Limited, a Wholly ...

Roquette Reshapes the Pharmaceutical Coating Landscape with an Innovative and High-Performance Platform Lill ...

Roquette Reshapes the Pharmaceutical Coating Landscape with an Innovative and High-Performance Platform Lille - 11 February 2025 - Roquette launches a new coatings platform, combining cutting-edge ...

Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Free Report) will likely be posting its quarterly earnings results before the ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

The majority shareholder of English sparkling wine producer Gusbourne is seeking to delist the company from the AIM market.

Pharmaceutical Market Size and Growth 2025 to 2034The global pharmaceutical market size was valued at USD 1,607.07 billion in ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

Leerink Partners upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a market perform rating to an ...